Ilan Kirsch is an expert in the field of Pediatrics. He attended Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. Ilan Kirsch is a published doctor. He published 34 publications, including: 'Topical resiquimod can induce disease regression, eradicate malignant T cells and enhance T cell effector functions in cutaneous T cell lymphoma.'
Dr. Kenneth M. Jaffe, MD | |
Dr. Abraham B. Bergman, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Ann N. Champoux, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Kelly N. Evans, MD | |
Dr. Eva M. Moore, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Sarah F. Munson, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Molly Capron, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Darren S. Migita, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Sara P. Chrisman, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Rita M. Mangione-Smith, MD | |
Dr. Florence Wu, MD | |
Dr. Michael G. Leu, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Andrew W. Hahn, MD | |
Dr. Erin R. Lane, MD | |
Dr. Lisa M. Cosgrove, DO
This Doctor is OpenDoctor Recommended. |
|
Dr. Jerry J. Zimmerman, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Howard E. Jeffries, MD
This Doctor is OpenDoctor Recommended. |